Loading…

Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India

ContextThe diagnosis of giant cell tumor of bone (GCTB) is difficult in small biopsies with unusual age of presentation, location, and extensive secondary changes. Most of the GCTBs harbor H3F3A G34W mutations with a subset of cases showing alternate G34V, G34R, and G34L mutations. ObjectivesTo anal...

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of pathology & microbiology 2022-07, Vol.65 (3), p.617-629
Main Authors: Kamble, Anvesh, Hui, Monalisa, Rao, KNageshwara, Narayanan, Ramakrishna, Reddy, BRajeev, Uppin, ShantveerG, Chandrasekhar, Patnala
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c318t-8858b85088f371b4adc023141a2e015a70d5328fabffc40a32d56149ecd71c443
cites
container_end_page 629
container_issue 3
container_start_page 617
container_title Indian journal of pathology & microbiology
container_volume 65
creator Kamble, Anvesh
Hui, Monalisa
Rao, KNageshwara
Narayanan, Ramakrishna
Reddy, BRajeev
Uppin, ShantveerG
Chandrasekhar, Patnala
description ContextThe diagnosis of giant cell tumor of bone (GCTB) is difficult in small biopsies with unusual age of presentation, location, and extensive secondary changes. Most of the GCTBs harbor H3F3A G34W mutations with a subset of cases showing alternate G34V, G34R, and G34L mutations. ObjectivesTo analyze the expression of anti-histone H3.3G34W antibody in different cellular components of GCTB across different locations and presentations (including the unusual ones) and validate the utility of this antibody in the diagnosis of GCTB and differentiate it from the other osteoclast-like giant-cell-rich lesions. DesignImmunohistochemistry was performed using anti-histone H3.3G34W antibody in the diagnosed cases of GCTB (136 cases of GCTB from 133 patients, including two malignant GCTBs) and other giant cell-containing lesions (62 cases). The presence of unequivocal crisp nuclear staining was considered positive. ResultsImmunohistochemistry revealed unequivocal nuclear positivity in the mononuclear cells in 87.3% of the cases of GCTB. Of these, most showed diffuse expression with moderate to strong intensity staining. The positive staining was restricted to the nuclei of mononuclear cells with the nuclei of osteoclastic giant cells being distinctly negative. In addition to conventional GCTBs, two cases each of multicentric and malignant GCTB showed positive staining. The other giant-cell containing lesions were distinctly negative. The present study showed a sensitivity of 87.3% with specificity and positive predictive value of 100%. ConclusionThe anti-histone G34W antibody is a highly sensitive and specific marker for the diagnosis of GCTB and differentiating it from its mimics. The positive staining is restricted to the mononuclear cell component of GCTB with sparing the osteoclastic giant cells further reiterating the fact that the mononuclear stromal cells are the true neoplastic component of GCTB.
doi_str_mv 10.4103/ijpm.ijpm_265_21
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2696007942</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2696007942</sourcerecordid><originalsourceid>FETCH-LOGICAL-c318t-8858b85088f371b4adc023141a2e015a70d5328fabffc40a32d56149ecd71c443</originalsourceid><addsrcrecordid>eNpNUbtu3DAQFIIEiOO4d7llGp350okqD0ZyZ8CAGxsuBYqPEx2JvJA8A_rS_E5WsQs33MXscPYxVXVNyUZQwm_8y2nerE_Ptk3P6KfqgnStqBvKyWfMedvWomPd1-pbzi-EbAVr-EX1dxeKrw8-lxgsHPiGw56LZ1AID9Es4DMoyDZkX_yrRdzA6I_jtEA-We2d1-Dn-RziuGro0c4Y0wKzSr9tAhcTlNGC8eoYYka16GDvUR60nSYo5xkZiA3YfwM7eFWTN6r4GGBQ2RrARAU1Le9_aSdBYyGDS3FeZ_PhOFlUCyVZ8AHuAjb7Xn1xasr26j1eVk-_fj7eHur7h_3d7e6-1pzKUkvZyEE2RErHWzoIZTRhnAqqmCW0US0xDWfSqcE5LYjizDRbKjqrTUu1EPyy-vGme0rxz9nm0uP-62Yq2HjOaEa3JaTtBEMqeaPqFHNO1vWn5PFMS09Jv3rY_7fvg4f8H9ydlKM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2696007942</pqid></control><display><type>article</type><title>Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India</title><source>Publicly Available Content Database</source><creator>Kamble, Anvesh ; Hui, Monalisa ; Rao, KNageshwara ; Narayanan, Ramakrishna ; Reddy, BRajeev ; Uppin, ShantveerG ; Chandrasekhar, Patnala</creator><creatorcontrib>Kamble, Anvesh ; Hui, Monalisa ; Rao, KNageshwara ; Narayanan, Ramakrishna ; Reddy, BRajeev ; Uppin, ShantveerG ; Chandrasekhar, Patnala</creatorcontrib><description>ContextThe diagnosis of giant cell tumor of bone (GCTB) is difficult in small biopsies with unusual age of presentation, location, and extensive secondary changes. Most of the GCTBs harbor H3F3A G34W mutations with a subset of cases showing alternate G34V, G34R, and G34L mutations. ObjectivesTo analyze the expression of anti-histone H3.3G34W antibody in different cellular components of GCTB across different locations and presentations (including the unusual ones) and validate the utility of this antibody in the diagnosis of GCTB and differentiate it from the other osteoclast-like giant-cell-rich lesions. DesignImmunohistochemistry was performed using anti-histone H3.3G34W antibody in the diagnosed cases of GCTB (136 cases of GCTB from 133 patients, including two malignant GCTBs) and other giant cell-containing lesions (62 cases). The presence of unequivocal crisp nuclear staining was considered positive. ResultsImmunohistochemistry revealed unequivocal nuclear positivity in the mononuclear cells in 87.3% of the cases of GCTB. Of these, most showed diffuse expression with moderate to strong intensity staining. The positive staining was restricted to the nuclei of mononuclear cells with the nuclei of osteoclastic giant cells being distinctly negative. In addition to conventional GCTBs, two cases each of multicentric and malignant GCTB showed positive staining. The other giant-cell containing lesions were distinctly negative. The present study showed a sensitivity of 87.3% with specificity and positive predictive value of 100%. ConclusionThe anti-histone G34W antibody is a highly sensitive and specific marker for the diagnosis of GCTB and differentiating it from its mimics. The positive staining is restricted to the mononuclear cell component of GCTB with sparing the osteoclastic giant cells further reiterating the fact that the mononuclear stromal cells are the true neoplastic component of GCTB.</description><identifier>ISSN: 0377-4929</identifier><identifier>EISSN: 0974-5130</identifier><identifier>DOI: 10.4103/ijpm.ijpm_265_21</identifier><language>eng</language><ispartof>Indian journal of pathology &amp; microbiology, 2022-07, Vol.65 (3), p.617-629</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c318t-8858b85088f371b4adc023141a2e015a70d5328fabffc40a32d56149ecd71c443</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906,36994</link.rule.ids></links><search><creatorcontrib>Kamble, Anvesh</creatorcontrib><creatorcontrib>Hui, Monalisa</creatorcontrib><creatorcontrib>Rao, KNageshwara</creatorcontrib><creatorcontrib>Narayanan, Ramakrishna</creatorcontrib><creatorcontrib>Reddy, BRajeev</creatorcontrib><creatorcontrib>Uppin, ShantveerG</creatorcontrib><creatorcontrib>Chandrasekhar, Patnala</creatorcontrib><title>Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India</title><title>Indian journal of pathology &amp; microbiology</title><description>ContextThe diagnosis of giant cell tumor of bone (GCTB) is difficult in small biopsies with unusual age of presentation, location, and extensive secondary changes. Most of the GCTBs harbor H3F3A G34W mutations with a subset of cases showing alternate G34V, G34R, and G34L mutations. ObjectivesTo analyze the expression of anti-histone H3.3G34W antibody in different cellular components of GCTB across different locations and presentations (including the unusual ones) and validate the utility of this antibody in the diagnosis of GCTB and differentiate it from the other osteoclast-like giant-cell-rich lesions. DesignImmunohistochemistry was performed using anti-histone H3.3G34W antibody in the diagnosed cases of GCTB (136 cases of GCTB from 133 patients, including two malignant GCTBs) and other giant cell-containing lesions (62 cases). The presence of unequivocal crisp nuclear staining was considered positive. ResultsImmunohistochemistry revealed unequivocal nuclear positivity in the mononuclear cells in 87.3% of the cases of GCTB. Of these, most showed diffuse expression with moderate to strong intensity staining. The positive staining was restricted to the nuclei of mononuclear cells with the nuclei of osteoclastic giant cells being distinctly negative. In addition to conventional GCTBs, two cases each of multicentric and malignant GCTB showed positive staining. The other giant-cell containing lesions were distinctly negative. The present study showed a sensitivity of 87.3% with specificity and positive predictive value of 100%. ConclusionThe anti-histone G34W antibody is a highly sensitive and specific marker for the diagnosis of GCTB and differentiating it from its mimics. The positive staining is restricted to the mononuclear cell component of GCTB with sparing the osteoclastic giant cells further reiterating the fact that the mononuclear stromal cells are the true neoplastic component of GCTB.</description><issn>0377-4929</issn><issn>0974-5130</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpNUbtu3DAQFIIEiOO4d7llGp350okqD0ZyZ8CAGxsuBYqPEx2JvJA8A_rS_E5WsQs33MXscPYxVXVNyUZQwm_8y2nerE_Ptk3P6KfqgnStqBvKyWfMedvWomPd1-pbzi-EbAVr-EX1dxeKrw8-lxgsHPiGw56LZ1AID9Es4DMoyDZkX_yrRdzA6I_jtEA-We2d1-Dn-RziuGro0c4Y0wKzSr9tAhcTlNGC8eoYYka16GDvUR60nSYo5xkZiA3YfwM7eFWTN6r4GGBQ2RrARAU1Le9_aSdBYyGDS3FeZ_PhOFlUCyVZ8AHuAjb7Xn1xasr26j1eVk-_fj7eHur7h_3d7e6-1pzKUkvZyEE2RErHWzoIZTRhnAqqmCW0US0xDWfSqcE5LYjizDRbKjqrTUu1EPyy-vGme0rxz9nm0uP-62Yq2HjOaEa3JaTtBEMqeaPqFHNO1vWn5PFMS09Jv3rY_7fvg4f8H9ydlKM</recordid><startdate>20220701</startdate><enddate>20220701</enddate><creator>Kamble, Anvesh</creator><creator>Hui, Monalisa</creator><creator>Rao, KNageshwara</creator><creator>Narayanan, Ramakrishna</creator><creator>Reddy, BRajeev</creator><creator>Uppin, ShantveerG</creator><creator>Chandrasekhar, Patnala</creator><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220701</creationdate><title>Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India</title><author>Kamble, Anvesh ; Hui, Monalisa ; Rao, KNageshwara ; Narayanan, Ramakrishna ; Reddy, BRajeev ; Uppin, ShantveerG ; Chandrasekhar, Patnala</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c318t-8858b85088f371b4adc023141a2e015a70d5328fabffc40a32d56149ecd71c443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kamble, Anvesh</creatorcontrib><creatorcontrib>Hui, Monalisa</creatorcontrib><creatorcontrib>Rao, KNageshwara</creatorcontrib><creatorcontrib>Narayanan, Ramakrishna</creatorcontrib><creatorcontrib>Reddy, BRajeev</creatorcontrib><creatorcontrib>Uppin, ShantveerG</creatorcontrib><creatorcontrib>Chandrasekhar, Patnala</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Indian journal of pathology &amp; microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kamble, Anvesh</au><au>Hui, Monalisa</au><au>Rao, KNageshwara</au><au>Narayanan, Ramakrishna</au><au>Reddy, BRajeev</au><au>Uppin, ShantveerG</au><au>Chandrasekhar, Patnala</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India</atitle><jtitle>Indian journal of pathology &amp; microbiology</jtitle><date>2022-07-01</date><risdate>2022</risdate><volume>65</volume><issue>3</issue><spage>617</spage><epage>629</epage><pages>617-629</pages><issn>0377-4929</issn><eissn>0974-5130</eissn><abstract>ContextThe diagnosis of giant cell tumor of bone (GCTB) is difficult in small biopsies with unusual age of presentation, location, and extensive secondary changes. Most of the GCTBs harbor H3F3A G34W mutations with a subset of cases showing alternate G34V, G34R, and G34L mutations. ObjectivesTo analyze the expression of anti-histone H3.3G34W antibody in different cellular components of GCTB across different locations and presentations (including the unusual ones) and validate the utility of this antibody in the diagnosis of GCTB and differentiate it from the other osteoclast-like giant-cell-rich lesions. DesignImmunohistochemistry was performed using anti-histone H3.3G34W antibody in the diagnosed cases of GCTB (136 cases of GCTB from 133 patients, including two malignant GCTBs) and other giant cell-containing lesions (62 cases). The presence of unequivocal crisp nuclear staining was considered positive. ResultsImmunohistochemistry revealed unequivocal nuclear positivity in the mononuclear cells in 87.3% of the cases of GCTB. Of these, most showed diffuse expression with moderate to strong intensity staining. The positive staining was restricted to the nuclei of mononuclear cells with the nuclei of osteoclastic giant cells being distinctly negative. In addition to conventional GCTBs, two cases each of multicentric and malignant GCTB showed positive staining. The other giant-cell containing lesions were distinctly negative. The present study showed a sensitivity of 87.3% with specificity and positive predictive value of 100%. ConclusionThe anti-histone G34W antibody is a highly sensitive and specific marker for the diagnosis of GCTB and differentiating it from its mimics. The positive staining is restricted to the mononuclear cell component of GCTB with sparing the osteoclastic giant cells further reiterating the fact that the mononuclear stromal cells are the true neoplastic component of GCTB.</abstract><doi>10.4103/ijpm.ijpm_265_21</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0377-4929
ispartof Indian journal of pathology & microbiology, 2022-07, Vol.65 (3), p.617-629
issn 0377-4929
0974-5130
language eng
recordid cdi_proquest_miscellaneous_2696007942
source Publicly Available Content Database
title Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T01%3A16%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-Histone%20H3.3%20G34W%20antibody%20is%20a%20sensitive%20and%20highly%20specific%20immunohistochemistry%20marker%20for%20the%20diagnosis%20of%20Giant%20cell%20tumor%20of%20bone.%20A%20validation%20based%20on%20analysis%20of%20198%20cases%20from%20a%20single%20centre%20in%20India&rft.jtitle=Indian%20journal%20of%20pathology%20&%20microbiology&rft.au=Kamble,%20Anvesh&rft.date=2022-07-01&rft.volume=65&rft.issue=3&rft.spage=617&rft.epage=629&rft.pages=617-629&rft.issn=0377-4929&rft.eissn=0974-5130&rft_id=info:doi/10.4103/ijpm.ijpm_265_21&rft_dat=%3Cproquest_cross%3E2696007942%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c318t-8858b85088f371b4adc023141a2e015a70d5328fabffc40a32d56149ecd71c443%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2696007942&rft_id=info:pmid/&rfr_iscdi=true